Search

Your search keyword '"Bodmer, J."' showing total 557 results
Start Over Author "Bodmer, J."

Refine your results

557 results on '"Bodmer, J."'

2. Time of dehairing alters pork quality development

Author

Wicks, J.C., primary, Zumbaugh, M.D., additional, Daniels, R.P., additional, Matarneh, S.K., additional, Venhuizen, M.D., additional, Elgin, J., additional, Bodmer, J., additional, Yen, C.-N., additional, Beline, M., additional, Shi, H., additional, Silva, S.L., additional, and Gerrard, D.E., additional

Published
2023
Full Text
View/download PDF

10. Genetic Characteristics of the HeLa Cell

Author

Hsu, Susan H., Schacter, Bernice Z., Delaney, Nancy L., Miller, Thomas B., McKusick, Victor A., Kennett, R. H., Bodmer, J. G., Young, D., and Bodmer, W. F.

Published
1976

13. Nomenclature for factors of the HLA system, 2000

Author

Marsh, S. G.E., Bodmer, J. G., Albert, E. D., Bodmer, W. F., Bontrop, R. E., Dupont, B., Erlich, H. A., Hansen, J. A., Mach, B., Mayr, W. R., Parham, P., Petersdorf, E. W., Sasazuki, T., Schreuder, G. M. Th., Strominger, J. L., Svejgaard, A., and Terasaki, P. I.

Published
2001

18. Nomenclature for factors of the HLA system, 1998

Author

Bodmer, J. G., Marsh, S. G. E., Albert, E. D., Bodmer, W. F., Bontrop, R. E., Dupont, B., Erlich, H. A., Hansen, J. A., Mach, B., Mayr, W. R., Parham, P., Petersdorf, E. W., Sasazuki, T., Schreuder, G. M. Th., Strominger, J. L., Svejgaard, A., and Terasaki, P. I.

Published
1999

22. NOMENCLATURE FOR FACTORS OF THE HLA SYSTEM, 1996

Author

Bodmer, J. G., Marsh, S. G. E., Albert, E. D., Bodmer, W. F., Bontrop, R. E., Charron, D., Dupont, B., Erlich, H. A., Fauchet, R., Mach, B., Mayr, W. R., Parham, P., Sasazuki, T., Th. Schreuder, G. M., Strominger, J. L., Svejgaard, A., and Terasaki, P. I.

Published
1997

26. DNA Polymorphism of HLA-DRβ and HLA-DPβ Genes

Author

So, A. K. L., Trowsdale, J., Bodmer, J. G., Bodmer, W. F., Albert, Ekkehard D., editor, Baur, Max P., editor, Mayr, Wolfgang R., editor, Bertrams, J., editor, Goldmann, S., editor, Grosse-Wilde, H., editor, Opelz, G., editor, Rittner, C., editor, Schendel, D. J., editor, Scholz, S., editor, and Wank, R., editor

Published
1984
Full Text
View/download PDF

27. The Expression of HLA-DR, DQ and DP Antigens on the Surface of Lymphocytes as Assessed by 2-D Polyacrylamide Gel Analysis of Immunoprecipitates

Author

Rudd, C. E., Bodmer, J. G., Bodmer, W. F., Crumpton, M. J., Albert, Ekkehard D., editor, Baur, Max P., editor, Mayr, Wolfgang R., editor, Bertrams, J., editor, Goldmann, S., editor, Grosse-Wilde, H., editor, Opelz, G., editor, Rittner, C., editor, Schendel, D. J., editor, Scholz, S., editor, and Wank, R., editor

Published
1984
Full Text
View/download PDF

29. HLA-A, B, C Monoclonal Antibodies

Author

Fauchet, R., Bodmer, J. G., Kennedy, L. J., Mazzilli, M. C., Müller, C., Raffoux, C., Richiardi, R., Albert, Ekkehard D., editor, Baur, Max P., editor, Mayr, Wolfgang R., editor, Bertrams, J., editor, Goldmann, S., editor, Grosse-Wilde, H., editor, Opelz, G., editor, Rittner, C., editor, Schendel, D. J., editor, Scholz, S., editor, and Wank, R., editor

Published
1984
Full Text
View/download PDF

31. HLA-D Region Monoclonal Antibodies

Author

Bodmer, J. G., Kennedy, L. J., Aizawa, M., Dawkins, R. L., Lepage, V., Mazzilli, M. C., Richiardi, P., Albert, Ekkehard D., editor, Baur, Max P., editor, Mayr, Wolfgang R., editor, Bertrams, J., editor, Goldmann, S., editor, Grosse-Wilde, H., editor, Opelz, G., editor, Rittner, C., editor, Schendel, D. J., editor, Scholz, S., editor, and Wank, R., editor

Published
1984
Full Text
View/download PDF

32. Biochemistry of Class II Antigens: Workshop Report

Author

Crumpton, M. J., Bodmer, J. G., Bodmer, W. F., Heyes, J. M., Lindsay, J., Rudd, C. E., Albert, Ekkehard D., editor, Baur, Max P., editor, Mayr, Wolfgang R., editor, Bertrams, J., editor, Goldmann, S., editor, Grosse-Wilde, H., editor, Opelz, G., editor, Rittner, C., editor, Schendel, D. J., editor, Scholz, S., editor, and Wank, R., editor

Published
1984
Full Text
View/download PDF

37. Serologic characterization of human Ia antigens using B cell lymphoid lines

Author

Bodmer, J., Young, D., Jones, E., Colin Barnstable, Goodfellow, P., Bodmer, W., Svejgaard, A., Thomsen, M., Trucco, M., Curtoni, E. S., Festenstein, H., and Sachs, J.

Abstract

This article discusses the detection of Ia antibodies in HLA-typing sera using B-cell lymphoid lines, the grouping of the sera into five preliminary clusters, and their associations with D-locus specificities.

Published
2016

42. Antigen Society #32 Report (DP)

Author

Johnson, A. H., Park, M. S., Bodmer, J. G., Kennedy, L., Marsh, S., Ferrara, G. B., Bratlie, A., Goldmann, S., Jakobson, B. K., Mervart, H., Mueller-Eckhardt, G., Svejgaard, A., Thorsby, E., Tsuji, K., and Dupont, Bo, editor

Published
1989
Full Text
View/download PDF

43. Antigen Society #27 Report DQw1

Author

Falk, J. A., Willshire, A. M., Bodmer, J. G., Marsh, S. G. E., Kennedy, L. J., Juji, T., Matsuki, K., Duquesnoy, R. J., Marrari, M., Johnson, A. H., Mervart, H., and Dupont, Bo, editor

Published
1989
Full Text
View/download PDF

45. Development of a recombinant toxin fragment vaccine for Clostridium difficile infection

Author

Karczewski, J., Zorman, J., Wang, S., Miezeiewski, M., Xie, J.F., Soring, K., Petrescu, I., Rogers, I., Thiriot, D.S., Cook, J.C., Chamberlin, M., Xoconostle, R.F., Nahas, D.D., Joyce, J.G., Bodmer, J.-L., Heinrichs, J.H., Secore, S., and Publica

Abstract

Clostridium difficile infection (CDI) is the major cause of antibiotic-associated diarrhea and pseudomembranous colitis, a disease associated with significant morbidity and mortality. The disease is mostly of nosocomial origin, with elderly patients undergoing anti-microbial therapy being particularly at risk. C difficile produces two large toxins: Toxin A (TcdA) and Toxin B (TcdB). The two toxins act synergistically to damage and impair the colonic epithelium, and are primarily responsible for the pathogenesis associated with CDI. The feasibility of toxin-based vaccination against C difficile is being vigorously investigated. A vaccine based on formaldehyde-inactivated Toxin A and Toxin B (toxoids) was reported to be safe and immunogenic in healthy volunteers and is now undergoing evaluation in clinical efficacy trials. In order to eliminate cytotoxic effects, a chemical inactivation step must be included in the manufacturing process of this toxin-based vaccine. In addition, the large-scale production of highly toxic antigens could be a challenging and costly process. Vaccines based on non-toxic fragments of genetically engineered versions of the toxins alleviate most of these limitations. We have evaluated a vaccine assembled from two recombinant fragments of TcdB and explored their potential as components of a novel experimental vaccine against CDI. Golden Syrian hamsters vaccinated with recombinant fragments of TcdB combined with full length TcdA (Toxoid A) developed high titer IgG responses and potent neutralizing antibody titers. We also show here that the recombinant vaccine protected animals against lethal challenge with C difficile spores, with efficacy equivalent to the toxoid vaccine. The development of a two-segment recombinant vaccine could provide several advantages over toxoid TcdA/TcdB such as improvements in manufacturability.

Published
2014

Catalog

Books, media, physical & digital resources
See catalog results